Global Traveler's Diarrhea Therapeutics Market Growth 2021-2026

  • receipt Report ID : 155199
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Traveler's Diarrhea Therapeutics will have significant change from previous year. By the most conservative estimates of global Traveler's Diarrhea Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 711.6 million in 2019. Over the next five years the Traveler's Diarrhea Therapeutics market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 945.6 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Immunization

Non-antibiotic Agents

Antibiotics

Anti-Motility Agents

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Adult Traveler's Diarrhea

Children Traveler's Diarrhea

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Salix Pharmaceuticals

P&G

Johnson & Johnson

Otsuka Pharma

Valneva

Shanghai United Cell

PaxVax

Livzon

Immuron

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Traveler's Diarrhea Therapeutics Consumption 2016-2026

2.1.2 Traveler's Diarrhea Therapeutics Consumption CAGR by Region

2.2 Traveler's Diarrhea Therapeutics Segment by Type

2.2.1 Immunization

2.2.2 Non-antibiotic Agents

2.2.3 Antibiotics

2.2.4 Anti-Motility Agents

2.2.5 Others

2.3 Traveler's Diarrhea Therapeutics Sales by Type

2.3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2016-2021)

2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2016-2021)

2.4 Traveler's Diarrhea Therapeutics Segment by Application

2.4.1 Adult Traveler's Diarrhea

2.4.2 Children Traveler's Diarrhea

2.5 Traveler's Diarrhea Therapeutics Sales by Application

2.5.1 Global Traveler's Diarrhea Therapeutics Sale Market Share by Application (2016-2021)

2.5.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Application (2016-2021)

2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2016-2021)

3 Global Traveler's Diarrhea Therapeutics by Company

3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company

3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Company (2019-2021)

3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2021)

3.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company

3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2021)

3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2021)

3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company

3.4 Global Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Traveler's Diarrhea Therapeutics Product Location Distribution

3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Traveler's Diarrhea Therapeutics by Region

4.1 Global Traveler's Diarrhea Therapeutics by Region

4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Region

4.1.2 Global Traveler's Diarrhea Therapeutics Revenue by Region

4.2 Americas Traveler's Diarrhea Therapeutics Sales Growth

4.3 APAC Traveler's Diarrhea Therapeutics Sales Growth

4.4 Europe Traveler's Diarrhea Therapeutics Sales Growth

4.5 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Growth

5 Americas

5.1 Americas Traveler's Diarrhea Therapeutics Sales by Country

5.1.1 Americas Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)

5.1.2 Americas Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)

5.2 Americas Traveler's Diarrhea Therapeutics Sales by Type

5.3 Americas Traveler's Diarrhea Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Traveler's Diarrhea Therapeutics Sales by Region

6.1.1 APAC Traveler's Diarrhea Therapeutics Sales by Region (2016-2021)

6.1.2 APAC Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021)

6.2 APAC Traveler's Diarrhea Therapeutics Sales by Type

6.3 APAC Traveler's Diarrhea Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Traveler's Diarrhea Therapeutics by Country

7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)

7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)

7.2 Europe Traveler's Diarrhea Therapeutics Sales by Type

7.3 Europe Traveler's Diarrhea Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Country

8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2016-2021)

8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021)

8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type

8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Traveler's Diarrhea Therapeutics Distributors

10.3 Traveler's Diarrhea Therapeutics Customer

11 Global Traveler's Diarrhea Therapeutics Market Forecast

11.1 Global Traveler's Diarrhea Therapeutics Forecast by Region

11.1.1 Global Traveler's Diarrhea Therapeutics Forecast by Regions (2021-2026)

11.2.2 Global Traveler's Diarrhea Therapeutics Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Traveler's Diarrhea Therapeutics Forecast by Type

11.7 Global Traveler's Diarrhea Therapeutics Forecast by Application

12 Key Players Analysis

12.1 Salix Pharmaceuticals

12.1.1 Salix Pharmaceuticals Salix Pharmaceuticals Company Information

12.1.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Offered

12.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Salix Pharmaceuticals Main Business Overview

12.1.5 Salix Pharmaceuticals Latest Developments

12.2 P&G

12.2.1 P&G Company Information

12.2.2 P&G Traveler's Diarrhea Therapeutics Product Offered

12.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 P&G Main Business Overview

12.2.5 P&G Latest Developments

12.3 Johnson & Johnson

12.3.1 Johnson & Johnson Company Information

12.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Offered

12.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Johnson & Johnson Main Business Overview

12.3.5 Johnson & Johnson Latest Developments

12.4 Otsuka Pharma

12.4.1 Otsuka Pharma Company Information

12.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Offered

12.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Otsuka Pharma Main Business Overview

12.4.5 Otsuka Pharma Latest Developments

12.5 Valneva

12.5.1 Valneva Company Information

12.5.2 Valneva Traveler's Diarrhea Therapeutics Product Offered

12.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Valneva Main Business Overview

12.5.5 Valneva Latest Developments

12.6 Shanghai United Cell

12.6.1 Shanghai United Cell Company Information

12.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Offered

12.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Shanghai United Cell Main Business Overview

12.6.5 Shanghai United Cell Latest Developments

12.7 PaxVax

12.7.1 PaxVax Company Information

12.7.2 PaxVax Traveler's Diarrhea Therapeutics Product Offered

12.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 PaxVax Main Business Overview

12.7.5 PaxVax Latest Developments

12.8 Livzon

12.8.1 Livzon Company Information

12.8.2 Livzon Traveler's Diarrhea Therapeutics Product Offered

12.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Livzon Main Business Overview

12.8.5 Livzon Latest Developments

12.9 Immuron

12.9.1 Immuron Company Information

12.9.2 Immuron Traveler's Diarrhea Therapeutics Product Offered

12.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Immuron Main Business Overview

12.9.5 Immuron Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Traveler's Diarrhea Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Immunization

Table 3. Major Players of Non-antibiotic Agents

Table 4. Major Players of Antibiotics

Table 5. Major Players of Anti-Motility Agents

Table 6. Major Players of Others

Table 7. Global Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)

Table 8. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

Table 9. Global Traveler's Diarrhea Therapeutics Revenue by Type (2016-2021) & ($ million)

Table 10. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2016-2021)

Table 11. Global Traveler's Diarrhea Therapeutics Sale Price by Type (2016-2021)

Table 12. Global Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)

Table 13. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Table 14. Global Traveler's Diarrhea Therapeutics Value by Application (2016-2021)

Table 15. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2016-2021)

Table 16. Global Traveler's Diarrhea Therapeutics Sale Price by Application (2016-2021)

Table 17. Global Traveler's Diarrhea Therapeutics Sales by Company (2019-2021) & (K Units)

Table 18. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2019-2021)

Table 19. Global Traveler's Diarrhea Therapeutics Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2019-2021)

Table 21. Global Traveler's Diarrhea Therapeutics Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution and Sales Area

Table 23. Players Traveler's Diarrhea Therapeutics Products Offered

Table 24. Traveler's Diarrhea Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Traveler's Diarrhea Therapeutics Sales by Region (2016-2021) (K Units)

Table 28. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2016-2021)

Table 29. Global Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2016-2021)

Table 31. Americas Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)

Table 32. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)

Table 33. Americas Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)

Table 35. Americas Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)

Table 36. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

Table 37. Americas Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)

Table 38. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Table 39. APAC Traveler's Diarrhea Therapeutics Sales by Region (2016-2021) & (K Units)

Table 40. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region (2016-2021)

Table 41. APAC Traveler's Diarrhea Therapeutics Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2016-2021)

Table 43. APAC Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)

Table 44. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

Table 45. APAC Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)

Table 46. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Table 47. Europe Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)

Table 48. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)

Table 49. Europe Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)

Table 51. Europe Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)

Table 52. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

Table 53. Europe Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)

Table 54. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2016-2021) & (K Units)

Table 56. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type (2016-2021) & (K Units)

Table 60. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application (2016-2021) & (K Units)

Table 62. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Table 63. Global Traveler's Diarrhea Therapeutics Sales Forecast by Type (2021-2026) & (K Units)

Table 64. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Type (2021-2026)

Table 65. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 66. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Type (2021-2026)

Table 67. Global Traveler's Diarrhea Therapeutics Sales Forecast by Application (2021-2026) & (K Units)

Table 68. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Application (2021-2026)

Table 69. Global Traveler's Diarrhea Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 70. Global Traveler's Diarrhea Therapeutics Revenue Market Share Forecast by Application (2021-2026)

Table 71. Salix Pharmaceuticals Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 72. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Offered

Table 73. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 74. Salix Pharmaceuticals Main Business

Table 75. Salix Pharmaceuticals Latest Developments

Table 76. P&G Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 77. P&G Traveler's Diarrhea Therapeutics Product Offered

Table 78. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 79. P&G Main Business

Table 80. P&G Latest Developments

Table 81. Johnson & Johnson Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 82. Johnson & Johnson Traveler's Diarrhea Therapeutics Product Offered

Table 83. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 84. Johnson & Johnson Main Business

Table 85. Johnson & Johnson Latest Developments

Table 86. Otsuka Pharma Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 87. Otsuka Pharma Traveler's Diarrhea Therapeutics Product Offered

Table 88. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 89. Otsuka Pharma Main Business

Table 90. Otsuka Pharma Latest Developments

Table 91. Valneva Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 92. Valneva Traveler's Diarrhea Therapeutics Product Offered

Table 93. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 94. Valneva Main Business

Table 95. Valneva Latest Developments

Table 96. Shanghai United Cell Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 97. Shanghai United Cell Traveler's Diarrhea Therapeutics Product Offered

Table 98. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 99. Shanghai United Cell Main Business

Table 100. Shanghai United Cell Latest Developments

Table 101. PaxVax Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 102. PaxVax Traveler's Diarrhea Therapeutics Product Offered

Table 103. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 104. PaxVax Main Business

Table 105. PaxVax Latest Developments

Table 106. Livzon Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 107. Livzon Traveler's Diarrhea Therapeutics Product Offered

Table 108. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 109. Livzon Main Business

Table 110. Livzon Latest Developments

Table 111. Immuron Basic Information, Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 112. Immuron Traveler's Diarrhea Therapeutics Product Offered

Table 113. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 114. Immuron Main Business

Table 115. Immuron Latest Developments

List of Figures

Figure 1. Picture of Traveler's Diarrhea Therapeutics

Figure 2. Traveler's Diarrhea Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Traveler's Diarrhea Therapeutics Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Traveler's Diarrhea Therapeutics Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Traveler's Diarrhea Therapeutics Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Immunization

Figure 10. Product Picture of Non-antibiotic Agents

Figure 11. Product Picture of Antibiotics

Figure 12. Product Picture of Anti-Motility Agents

Figure 13. Product Picture of Others

Figure 14. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020

Figure 15. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2016-2021)

Figure 16. Traveler's Diarrhea Therapeutics Consumed in Adult Traveler's Diarrhea

Figure 17. Global Traveler's Diarrhea Therapeutics Market: Adult Traveler's Diarrhea (2016-2021) & (K Units)

Figure 18. Traveler's Diarrhea Therapeutics Consumed in Children Traveler's Diarrhea

Figure 19. Global Traveler's Diarrhea Therapeutics Market: Children Traveler's Diarrhea (2016-2021) & (K Units)

Figure 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2016-2021)

Figure 21. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application in 2020

Figure 22. Global Traveler's Diarrhea Therapeutics Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company in 2020

Figure 24. Global Traveler's Diarrhea Therapeutics Sales Market Share by Regions (2016-2021)

Figure 25. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region in 2020

Figure 26. Americas Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)

Figure 27. Americas Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)

Figure 28. APAC Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)

Figure 29. APAC Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)

Figure 30. Europe Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)

Figure 31. Europe Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Traveler's Diarrhea Therapeutics Sales 2016-2021 (K Units)

Figure 33. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue 2016-2021 ($ Millions)

Figure 34. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020

Figure 35. Americas Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020

Figure 36. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020

Figure 37. Americas Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020

Figure 38. United States Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Region in 2020

Figure 43. APAC Traveler's Diarrhea Therapeutics Revenue Market Share by Regions in 2020

Figure 44. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020

Figure 45. APAC Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020

Figure 46. China Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020

Figure 53. Europe Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020

Figure 54. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020

Figure 55. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020

Figure 56. Germany Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Traveler's Diarrhea Therapeutics Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2020

Figure 65. Egypt Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Traveler's Diarrhea Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles